When was ProteoWise founded?

ProteoWise was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is ProteoWise located?

ProteoWise is headquartered in New Haven, United States.

How many employees does ProteoWise have?

As of Aug 31, 2026, the latest employee count at ProteoWise is 13.

Is ProteoWise a funded company?

ProteoWise is a funded company, having raised a total of $8.6M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 27, 2020.

When was the latest funding round of ProteoWise?

ProteoWise's latest funding was a $***** Series A round on Dec 06, 2024, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.3B in funding in 2026 to date.

Where does ProteoWise rank among its competitors?

ProteoWise ranks 5th amongst 18 active competitors, of which 9 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Pictor, which secured $7.5M in Jun, 2026.

Who are the top competitors of ProteoWise?

ProteoWise's top competitors include NanoMosaic, Portal Biotech and 10x Science. Among them, Pictor secured the most recent funding round in June, 2026.

ProteoWise - 2026 Company Profile, Team, Funding & Competitors

Company Details

Proteo Wise involvs in the proteomic analysis. The company's patented product 3 Dimensional Nano Scale Protein Capture (3D-NPC) technology is used for protein analysis. In this technology, the nanoscale material binds with the protein and then with antibody probes to give result.

Website: proteowise.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

New Haven, United States

Stage

Series A

Total Funding

$8.6M in 3 rounds

Latest Funding Round

Series A, Dec 06, 2024, $*****

Investors

Connecticut Innovations & 4 more

Ranked

5^th among 18 active competitors

Employee Count

13 as on Aug 31, 2026

Similar Companies

NanoMosaic & 16 more

View ProteoWise's full profile

ProteoWise has raised a total funding of $8.6M over 3 rounds. Its first funding round was on Mar 27, 2020. ProteoWise has 5 institutional investors.

Here is the list of recent funding rounds of ProteoWise:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 06, 2024	1888575	Series A	2245156	5118874	9698195	3105340
Jun 01, 2020	2454302	Grant (prize money)	3035875	1323100	5958764	HHS
Mar 27, 2020	2904963	Series A	9180867	7552287	7668324	8194542

Access funding benchmarks and valuations. Sign up today!

View details of ProteoWise's funding rounds and investors

The founders of ProteoWise are Mikhail Kostylev and Stephen M Strittmatter. Erik Gunther is the CEO of ProteoWise.

Here are the details of ProteoWise's key team members:

Mikhail Kostylev: Co-Founder of ProteoWise.
Stephen M Strittmatter: Co-Founder of ProteoWise.
Erik Gunther: CEO of ProteoWise.

View details of ProteoWise's Founder profiles and Board Members

ProteoWise's employee count trend

ProteoWise has 13 employees as of Aug 26. Here is ProteoWise's employee count trend over the years:

Uncover ProteoWise's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ProteoWise include NanoMosaic, Portal Biotech and 10x Science. Here is the list of Top 10 competitors of ProteoWise, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NanoMosaic 2018, Woburn (United States), Series A	Manufacturer of system for early disease detection and prognosis	$44.8M	RA Capital Management, Pura Vida Investments ... & 3 others	54/100
2nd	Portal Biotech 2021, London (United Kingdom), Series A	Developer of biosensing technology that utilizes bioengineered nanopores to analyze proteins and metabolomics	$45.4M	Earlybird, NIF & 10 others	51/100
3rd	10x Science 2025, San Francisco (United States), Seed	Provider of AI-native protein characterization platform for biopharma	$5.3M	Initialized Capital, Y Combinator & 1 others	42/100
4th	Inanovate 2006, Durham (United States), Series C	Provider of multiplexed protein quantification platform for clinical diagnostics and research	$13M	Badlands Capital, America’s Seed Fund & 3 others	42/100
5th	ProteoWise 2018, New Haven (United States), Series A	Provider of a platform for the analysis of proteomics	$8.6M	Connecticut Innovations, UniWill Ventures ... & 3 others	40/100
6th	Atantares 2020, Cambridge (United States), Seed	Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies	$14M	Asia Green Fund, Qiming Venture Partners & 6 others	39/100
7th	Novilytic 2021, West Lafayette (United States), Seed	Developer of molecular recognition system to detect the quality of medicines	$3.08M	Elevate Ventures, Purdue Foundry & 3 others	38/100
8th	Pictor 2025, Carlsbad (United States), Series A	Developer of platforms for targeted protein analysis and diagnostic testing	$30M	-	30/100
9th	GenNext Technologies 2016, Montara (United States), Funding Raised	Developer of a device for protein structural analysis	-	HHS	29/100
10th	Protein Stable 2019, Leatherhead (United Kingdom), Unfunded	Provider of protein stability measurement systems for research labs	-	-	25/100